Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Silicon Laboratories (SLAB): Are Hedge Funds Right About This Stock?

Page 1 of 2

Is it smart to be bullish on Silicon Laboratories (NASDAQ:SLAB)?

To the average investor, there are many indicators market participants can use to watch their holdings. A duo of the most under-the-radar are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the best hedge fund managers can trounce the market by a very impressive amount (see just how much).

Just as necessary, optimistic insider trading activity is another way to look at the investments you’re interested in. Just as you’d expect, there are a variety of incentives for a corporate insider to get rid of shares of his or her company, but just one, very clear reason why they would initiate a purchase. Plenty of empirical studies have demonstrated the market-beating potential of this method if you know what to do (learn more here).

Silicon Laboratories

Keeping this in mind, it’s important to examine the newest info surrounding Silicon Laboratories (NASDAQ:SLAB).

What does the smart money think about Silicon Laboratories (NASDAQ:SLAB)?

At Q2’s end, a total of 14 of the hedge funds we track were bullish in this stock, a change of 0% from the first quarter. With hedgies’ sentiment swirling, there exists a few key hedge fund managers who were upping their stakes significantly.

When using filings from the hedgies we track, Alkeon Capital Management, managed by Panayotis Sparaggis, holds the biggest position in Silicon Laboratories (NASDAQ:SLAB). Alkeon Capital Management has a $65.4 million position in the stock, comprising 1.5% of its 13F portfolio. Coming in second is Phill Gross and Robert Atchinson of Adage Capital Management, with a $64.9 million position; the fund has 0.2% of its 13F portfolio invested in the stock. Some other peers that are bullish include Ken Griffin’s Citadel Investment Group, Clint Carlson’s Carlson Capital and Jim Simons’s Renaissance Technologies.

Because Silicon Laboratories (NASDAQ:SLAB) has witnessed bearish sentiment from the entirety of the hedge funds we track, we can see that there is a sect of fund managers who sold off their positions entirely at the end of the second quarter. At the top of the heap, John Overdeck and David Siegel’s Two Sigma Advisors sold off the biggest stake of the 450+ funds we key on, worth about $3.3 million in stock, and D. E. Shaw of D E Shaw was right behind this move, as the fund said goodbye to about $2.4 million worth. These moves are intriguing to say the least, as aggregate hedge fund interest stayed the same (this is a bearish signal in our experience).

How have insiders been trading Silicon Laboratories (NASDAQ:SLAB)?

Insider buying is at its handiest when the company we’re looking at has experienced transactions within the past six months. Over the latest 180-day time period, Silicon Laboratories (NASDAQ:SLAB) has experienced zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll also take a look at the relationship between both of these indicators in other stocks similar to Silicon Laboratories (NASDAQ:SLAB). These stocks are Himax Technologies, Inc. (ADR) (NASDAQ:HIMX), First Solar, Inc. (NASDAQ:FSLR), SolarCity Corp (NASDAQ:SCTY), Cirrus Logic, Inc. (NASDAQ:CRUS), and SunPower Corporation (NASDAQ:SPWR). This group of stocks are the members of the semiconductor – specialized industry and their market caps are similar to SLAB’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!